Following a sharp decline in sales, Swedish medtech company Miris is planning a SEK 20 million rights issue. At the same time ...
A new prostate cancer pill achieved a tumour response in 75 per cent of patients whose tumours could be measured in a phase I ...
Roche’s investigational cancer drug divarasib reduced the risk of death by 44 per cent compared with existing treatments in a phase III trial involving patients with lung cancer.
New treatments for ALS are raising hopes among researchers. “The earlier a patient receives targeted gene therapy, the ...
In May, Vitrolife announced that Bronwyn Brophy O'Connor had decided to step down as President and CEO to take up the same ...
AstraZeneca’s experimental cancer treatment sone-ve delivered longer survival than analysts had expected in a phase III trial ...
New treatments for ALS are raising hopes among researchers. “The earlier a patient receives targeted gene therapy, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results